Tandem Diabetes (TNDM) director Twomey reports RSU grant and 8,759-unit vesting
Rhea-AI Filing Summary
Tandem Diabetes Care director Christopher J. Twomey reported equity compensation activity. On May 20, 2026, he received a grant of 10,220 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock or cash under the 2023 Long-Term Incentive Plan.
On May 21, 2026, a prior grant of 8,759 RSUs (awarded on May 21, 2025) fully vested and converted into common shares, increasing his directly held common stock to 24,434 shares. Additional common shares are held indirectly by the Chris J. Twomey and Rebecca J. Twomey Family Trust and by Twomey Family Investments, LLC, where he shares voting and investment power and disclaims beneficial ownership except for his proportionate pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 8,759 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,759 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 10,220 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.
- F2. The securities are directly owned by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over these securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.
- F3. Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- F4. RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
- F5. On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Key Figures
Key Terms
Restricted Stock Unit financial
derivative security financial
beneficial ownership financial
pecuniary interest financial
Long-Term Incentive Plan financial
AI-generated analysis. How Rhea-AI works. Not financial advice.